Abstract
Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study (P13-5.003)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have